PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.96%
Negative net income growth while MCHP stands at 185.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.40%
Less D&A growth vs. MCHP's 0.81%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-70.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-27.54%
Both cut yoy SBC, with MCHP at -3.97%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-630.56%
Both reduce yoy usage, with MCHP at -205.41%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-254.29%
Both yoy AR lines negative, with MCHP at -53.45%. Martin Whitman would suspect an overall sector lean approach or softer demand.
148.12%
Inventory shrinking or stable vs. MCHP's 8500.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-117.81%
Negative yoy AP while MCHP is 22.72%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
40.91%
Growth well above MCHP's 3.36%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
100.00%
Well above MCHP's 10.12%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-16.10%
Both yoy CFO lines are negative, with MCHP at -0.13%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-12.31%
Negative yoy CapEx while MCHP is 20.34%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
12.31%
Acquisition growth of 12.31% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-920.08%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-71.82%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-28.23%
Both yoy lines negative, with MCHP at -44.37%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-252.33%
Both yoy lines negative, with MCHP at -51.41%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment above 1.5x MCHP's 18.53%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
41.38%
We slightly raise equity while MCHP is negative at -44.06%. John Neff sees competitor possibly preserving share count or buying back shares.
98.30%
Buyback growth of 98.30% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.